IDEAYA Biosciences, Inc. (IDYA) Operating cash flow 2017–2025
IDEAYA Biosciences, Inc. (IDYA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$71.1MFY2025 · since FY2017: -$12.2M → -$71.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$71.1M | +71.3% |
| FY2024 | -$247.6M | -114.9% |
| FY2023 | -$115.2M | -32.2% |
| FY2022 | -$87.2M | -56.3% |
| FY2021 | -$55.8M | -200.6% |
| FY2020 | $55.5M | +241.1% |
| FY2019 | -$39.3M | -42.3% |
| FY2018 | -$27.6M | -125.9% |
| FY2017 | -$12.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating marginIDYA Free cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →